Log in to save to my catalogue

A Direct Comparison of Intravenous Enoxaparin With Unfractionated Heparin in Primary Percutaneous Co...

A Direct Comparison of Intravenous Enoxaparin With Unfractionated Heparin in Primary Percutaneous Co...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1443403688

A Direct Comparison of Intravenous Enoxaparin With Unfractionated Heparin in Primary Percutaneous Coronary Intervention (from the ATOLL Trial)

About this item

Full title

A Direct Comparison of Intravenous Enoxaparin With Unfractionated Heparin in Primary Percutaneous Coronary Intervention (from the ATOLL Trial)

Publisher

United States: Elsevier Inc

Journal title

The American journal of cardiology, 2013-11, Vol.112 (9), p.1367-1372

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Intravenous enoxaparin did not reduce significantly the primary end point (p = 0.06) compared with unfractionated heparin (UFH) in the randomized Acute Myocardial Infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up (ATOLL) trial. We...

Alternative Titles

Full title

A Direct Comparison of Intravenous Enoxaparin With Unfractionated Heparin in Primary Percutaneous Coronary Intervention (from the ATOLL Trial)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1443403688

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1443403688

Other Identifiers

ISSN

0002-9149

E-ISSN

1879-1913

DOI

10.1016/j.amjcard.2013.07.003

How to access this item